Lupin

Lupin Official page of Lupin - A global pharmaceutical company with over 50 years of expertise in by prescriptions.
(267)

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets in the U.S., India, South Africa and across Asia Pacific (APAC), Latin America (LATAM), Europe and Middle-East regions. The Company enjoys leadership position in the cardiovascular, anti-diabetic, and respiratory segments and has significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS) and women’s health areas. Lupin is the third largest pharmaceutical company in the U.S. The company invested 9.6% of its revenue on research and development in FY21. Lupin has 15 manufacturing sites, 7 research centers, more than 20,000 professionals working globally, and has been consistently recognized as a 'Great Place to Work' in the Biotechnology & Pharmaceuticals sector. Please visit www.lupin.com for more information.

31/12/2025

As we step into 2026, we carry forward our commitment to enabling healthier and enriching lives. Here is to a New Year filled with purpose, progress and possibilities-wishing everyone good health and a brighter tomorrow.

Our Purpose is more than words - it is a promise we live by.A promise to deliver meaningful treatments, make complex, cu...
30/12/2025

Our Purpose is more than words - it is a promise we live by.
A promise to deliver meaningful treatments, make complex, cutting-edge solutions accessible to all and support underserved communities.
It is what unites all of us at Lupin, and defines the ‘why’ behind everything we do.

Lupin entered into an exclusive License, Supply and Distribution agreement with Gan & Lee Pharmaceuticals, headquartered...
30/12/2025

Lupin entered into an exclusive License, Supply and Distribution agreement with Gan & Lee Pharmaceuticals, headquartered in China, for a novel fortnightly GLP-1 receptor agonist, Bofanglutide. The agreement strengthens Lupin’s diabetes portfolio and accelerates its presence in the obesity segment. Read More: https://bit.ly/4jejb6q


Some parts of your body work in unique ways you don’t usually think about.Take a guess and see the answer in the post! ...
29/12/2025

Some parts of your body work in unique ways you don’t usually think about.
Take a guess and see the answer in the post!

Lupin has won the Gold Medal and the Safety First Factory Award at the Indian Green Manufacturing Challenge Awards 2025....
29/12/2025

Lupin has won the Gold Medal and the Safety First Factory Award at the Indian Green Manufacturing Challenge Awards 2025.

This achievement reflects our unwavering commitment to sustainability, operational excellence, and maintaining the highest standards of safety across our facilities.

Together, we continue to build a greener, safer future.

Leatitia Gradwell finds joy in helping others and solving challenges while contributing to better health and well-being....
26/12/2025

Leatitia Gradwell finds joy in helping others and solving challenges while contributing to better health and well-being.

25/12/2025

Celebrating the magic of Christmas and stepping into a New Year with renewed purpose, joy and positivity.
Lupin wishes you and your loved ones a joyful and Merry Christmas.

Vinita Gupta, CEO, Lupin, in her conversation with Business Today, outlined Lupin’s forward-looking strategy — driven by...
24/12/2025

Vinita Gupta, CEO, Lupin, in her conversation with Business Today, outlined Lupin’s forward-looking strategy — driven by high‑barrier product innovation, operational efficiency and expansion across key markets. Read More: https://bit.ly/3LhDu6n

Address

Mumbai

Opening Hours

Monday 9:30am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+912266402323

Website

Alerts

Be the first to know and let us send you an email when Lupin posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Lupin:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

A global pharmaceutical company with 50 years of expertise in bringing you better health with care.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets in the U.S., India, South Africa and across Asia Pacific (APAC), Latin America (LATAM), Europe and Middle-East regions.

The Company enjoys leadership position in the cardiovascular, anti-diabetic, and respiratory segments and has significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS) and women’s health areas. Lupin is the third largest pharmaceutical company in the U.S. by prescriptions and in India by global revenues. The Company invests 9.6 % of its revenues on research and development.

Lupin has fifteen manufacturing sites, seven research centers, more than 20,000 professionals working globally, and has been consistently recognized as a 'Great Place to Work' in the Biotechnology & Pharmaceuticals sector.